Singapore markets open in 6 hours 7 minutes

JNJ Jun 2025 145.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
18.50+4.55 (+32.62%)
As of 09:32AM EDT. Market open.
Full screen
Previous close13.95
Expiry date2025-06-20
Day's range15.90 - 18.75
Contract rangeN/A
Open interest189
  • Yahoo Finance Video

    Chip stocks under pressure, pharmaceuticals rise: Morning Brief

    On today's episode of Morning Brief, hosts Seana Smith and Madison Mills break down the market open and some of the biggest stories hitting the market. The major market averages (^DJI, ^IXIC, ^GSPC) are under pressure Wednesday morning, with the Nasdaq Composite falling by over 300 points — or over 1.6% — as semiconductor stocks drag down the tech-heavy indexes. As a new report from Bloomberg outlines the Biden administration's plans for stricter trade regulations on chip exports to China, Principal Asset Management chief global strategist Seema Shah explains: "In a way, this is not unexpected. I think everyone has been anticipating that,as you see this continuation of US-China tensions, that, unfortunately, some of these chip makers, technology almost falls right into the spotlight." However, InsingerGilissen senior analyst Jos Versteeg believes ASML (ASML) will continue to perform well despite the news, saying, "When you look at China, China semiconductor manufacturing, they are using mainly low-end chips and the US wants them to keep on producing low-end chips because the world needs it." Meanwhile, the US political landscape is heating up. In a recent Bloomberg interview, former President Donald Trump said he would allow Federal Reserve Chair Jerome Powell to complete his term if reelected, as long as Trump thinks Powell is "doing the right thing." However, Trump doesn't think the Fed should cut rates before the election in November because that could help President Biden's reelection prospects. Tesla (TSLA) CEO Elon Musk, who recently backed Trump in the 2024 election, announced on X, formerly Twitter, that he plans to relocate the headquarters of both SpaceX and X to Austin, Texas. This move is in response to a new California law regarding transgender rights in schools, bringing increased rhetoric to some of the biggest issues dominating the November election. Johnson & Johnson (JNJ) posted its second quarter earnings Wednesday morning, beating estimates on its top and bottom lines. However, the pharmaceutical giant slashed its full-year profit forecast. Shares of Roche (ROG.SW) are also moving higher on Wednesday as the company reported positive results from its obesity drug trial for a once-a-day oral pill currently labeled CT-996. This post was written by Melanie Riehl

  • Yahoo Finance Video

    J&J posts Q2 earnings beat, but slashes 2024 profit forecast

    Pharmaceutical giant Johnson & Johnson (JNJ) posted its second-quarter earnings Wednesday morning, beating estimates on its top and bottom lines. JNJ also slashed its full-year profit forecast. Yahoo Finance health reporter Anjalee Khemlani highlights JNJ's earnings report on The Morning Brief. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Luke Carberry Mogan.

  • Benzinga

    Johnson And Johnson Continues To Focus On Medical Innovation

    On Wednesday, Johnson & Johnson (NYSE: JNJ) reported its second quarter results that reflected a strong momentum of its medtech and innovative medicine divisions. Although one-time charges prevented topline growth from reaching the bottom line, Johnson and Johnson showed it continues to advance its drug pipeline for a new medical era, with significant clinical milestones being attained throughout the quarter. Second Quarter Highlights For the June quarter, Johnson & Johnson reported topline grow